Stock News

News follows a 1-for-15 reverse share split by the company at the end of August and ensuing loss of stock value

Yagci brings over 15 years experience as an institutional investor in medical devices and healthcare services to the table.

Reunion still holds 21.84% interest in Field Trip Health & Wellness

Company still expects to observe revenue growth for the remainder of 2022

More millionaires are made during recessions than at any other time, and the difference is time, due diligence and sin stocks.

Canadian company set to focus clinical trials down under, announces regulatory update

Company growth within Colombia and Europe responsible for financial success this quarter

Cannabis revenue of $66 million during the fourth quarter represented a decline of 35 per cent

MyHempisphere program to be tailored to each customer

Industry is set to expand by approximately US$155 billion between 2020-2030

Nova’s sales growth resulted from new retail stores, transition to Value Buds low-cost model

Cannabis stock spikes fueled by Reddit traders this week have little to do with fundamentals, says TradingView GM Pierce Crosby

Despite reporting a $829M Q3 loss, shares are up as the Canadian weed giant predicts US legalization will spur profits

While initial research suggests CBD is well-tolerated in pups, even Canopy recommends consulting your vet before starting any cannabis treatment

The Ontario-based super-producer saw Q2 sales grow 23% while it adjusted its US expansion strategy for a Democrat in the White House

The once-promising producer previewed impairment charges of $1.8B, termination of UFC deal, while appointing Miguel Martin head boss

Raymond James analysts forecast the vegetable grower will take full ownership of its Pure Sunfarms joint venture and a 20% share of Canada's weed market

Partnership goes from 'game-on' to game-over as Aurora exits, refutes wrongdoing

Its Simply Bare brand has been a hit with consumers, but can the firm translate quality product into profit? Yes, say analysts

Quarterly reports from 10 cannabis companies paint two different pictures on either side of the US-Canada border

Company stock drops 20%, throws out previous profit targets for fiscal 2021

Numinus Wellness goes public on the prediction that regulation is coming

The pot stock popped 36 per cent this week while reporting $0.04 a gram production costs in Colombia

Shares in the Chicago-based company dropped 11% after posting a US$45.2 million fourth-quarter net loss

Stateside sales accounted for 93% of revenues in the last quarter of 2019

The company reported steady growth over the latest fiscal period, but scaled back annual projections due to coronavirus concerns

The recent COVID-19-related sales bump won't last as demand for cannabis isn't as inelastic during a recession as some think, Jerome Hass of Lightwater Partners says

The producer's cash position looks grim going into the coming months

The initial report provided a lengthy case as to how the Canadian-headquartered company had roots in an auto-enrichment scheme

Professor says claims about company with ‘brilliant’ strategy could hurt reputation of the country's other operators for some time

A university-run clinical trial showed a significant reduction of insomnia with minimal side effects

The pot giant announced a third-quarter net loss of $1.3 billion and a 27 per cent decline in cannabis sales

Aurora Cannabis announced Thursday its CEO is stepping down, making it the sixth company to part with its top boss in 2020

The REIT has been notably resistant to the downturn of the cannabis market

Treatments for back pain and hemorrhoids will hit shelves mid-2020, company says

Company says its quality cannabis 2.0 products will keep its revenues growing in future quarters

David Klein also spent his first day as the new head of Canopy

With its hands-on clientele, GrowGeneration has side-stepped the shortfalls of the mainstream industry

The company’s stock rose 17 per cent following news of technological advancement

The Quebec-based producer diluted the value of its existing stock by issuing more shares as it also reported a $2.4 million write-down on 'cannabis trim'